Dr. Meehan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-650-4628Fax+1 603-650-2334
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1989 - 1993
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1986 - 1989
Georgetown University School of MedicineClass of 1986
Certifications & Licensure
NH State Medical License 1992 - 2026
DC State Medical License 1994 - 2002
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma Start of enrollment: 2007 Jan 01
- Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies Start of enrollment: 2004 Jun 01
- Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF Start of enrollment: 2003 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation: A Randomized Clinical Trial.Gregory A Abel, Haesook T Kim, Ira Zackon, Edwin T Alyea, Alexandra S Bailey
JAMA Oncology. 2025-03-01 - Novel Neurocognitive Testing Tool for Early Neurotoxicity Detection Following Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-cell Therapy: A Pilot Study.Arvind Suresh, Heather A Wishart, Maeen N Arslan, Raphael A Lizcano, Parth S Shah
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-24 - 2 citationsPorcine-human glioma xenograft model. Immunosuppression and model reproducibility.P Jack Hoopes, Armin D Tavakkoli, Karen A Moodie, Kirk J Maurer, Kenneth R Meehan
Cancer Treatment and Research Communications. 2024-01-01
Grant Support
- NK Cell Activating Receptors On Effector Cells In Myeloma Patients Receiving TraNational Center For Research Resources2009–2010
- Mechanisms Of Coagulation Activation In CancerNational Cancer Institute1991–1993
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
